Robin Roberts Diagnosed With Rare Blood Disorder

Robin Roberts
Robin Roberts announced on Good Morning America that she has been diagnosed with a rare blood and bone marrow disorder called MDS, and will undergo a bone marrow transplant. Sadly, this news happens five years after she battled breast cancer.

Celebrate great health! LIKE on Facebook!

Speaking on “Good Morning America” and writing on her blog post, Roberts said the disease was once called preleukemia, and is a complication from the treatment she received to beat breast cancer in 2007.

On the “GMA” website, Roberts wrote that, while there are some “scary” statistics about the disease, her doctors have told her she is young and fit enough to beat it.

READ: MDS: A Rare Disease Of The Blood

Roberts made the announcement toward the end of Monday’s “GMA,” surrounded by her co-hosts and with former co-host Diane Sawyer (whom she called “my Thelma”) in attendance.

“Sometimes treatment for cancer can lead to other serious medical issues and that’s what I’m facing right now,” she said. “The reason I am sharing this with everybody right now is because later today I begin what’s known as pre-treatment.”

Roberts said that a tube was being added to her arm Monday afternoon. “I didn’t want you to be concerned if you saw a bandage tomorrow,” she said. “It’s going to be there to draw blood … and also to administer drugs.”

She said that she will be “out for a chunk of time” after she receives a bone marrow transplant from her sister, who doctors said was a “perfect match” for her.

She pledged to overcome the disease.

“I’m going to beat this,” she said, choking up. “My doctors say it and my faith says it to me.” She received a round of applause at the end of her comments.

READ: 10 Cancer Symptoms Men Ignore

In her blog post, Roberts elaborated on her diagnosis:

I received my MDS diagnosis on the very day that Good Morning America finally beat the Today Show for the first time in 16 years. Talk about your highs and lows! Then a few weeks ago, during a rather unpleasant procedure to extract bone marrow for testing, I received word that I would interview President Obama the next day. The combination of landing the biggest interview of my career and having a drill in my back reminds me that God only gives us what we can handle and that it helps to have a good sense of humor when we run smack into the absurdity of life.

Bottom line: I’ve been living with this diagnosis for awhile and will continue to anchor GMA. I love what I do and the people with whom I do it. Along with my faith, family and friends, all of you at ABC News give me the motivation and energy to face this challenge.

Watch Robin Make Her MDS Announcement:

[ione_embed src= service=kaltura width=392 height=221]


Would you subscribe to a service where you can see a black doctor anytime via video chat for $19 a month?

MDS: A Rare Disease Of The Blood

Microscopic image of red blood cells
Myelodysplastic syndromes (MDS) are a rare group of blood disorders that occur as a result of improper development of blood cells within the bone marrow.

READ: Robin Roberts Diagnosed With Rare Blood Disorder

About 10,000 to 15,000 people are diagnosed with myelodysplastic syndromes in the United States each year. Although MDS can affect people of any age, more than 80% of cases are in people over age 60. MDS is more common in men than in women.

Celebrate great health! LIKE on Facebook!

General symptoms associated with MDS include fatigue, dizziness, weakness, bruising, bleeding, frequent infections, and headaches. In some cases, MDS may progress to life-threatening failure of the bone marrow or develop into an acute leukemia. The exact cause of MDS is unknown. There are no certain environmental risk factors.

Causes of MDS

In MDS, the bone marrow does not make enough normal blood cells for the body. One, two or all three types of blood cells — red blood cells, white blood cells and platelets — may be affected. The marrow may also make immature cells called blasts. Blasts normally develop into red blood cells, white blood cells or platelets. In MDS, the blasts are abnormal and do not develop or function normally.

Most often the cause of the changes to the bone marrow is unknown. This is called de novo MDS. In a small number of people, MDS might be linked to heavy exposure to some chemicals, such as certain solvents, or to radiation. MDS can also be caused by treatment with chemotherapy or radiation therapy for other diseases. This is called treatment-related MDS or secondary MDS. Treatment-related MDS is often more severe and difficult to treat than de novo MDS.

MDS Symptoms

The symptoms of MDS depend on how severe the disease is. Many people with MDS have no symptoms when they are diagnosed. Their disease is found through a routine blood test. If a person does have symptoms, they are caused by low numbers of blood cells:

  • Red blood cells carry oxygen throughout the body. Low numbers can lead to anemia — feeling tired or weak, being short of breath and looking pale. Anemia is the most common symptom of MDS.
  • White blood cells fight infection. Low numbers can lead to fever and frequent infections.
  • Platelets control bleeding. Low numbers can lead to easy bleeding or bruising.

In severe MDS, infection or uncontrolled bleeding can be life-threatening.


MDS is one of several diseases with these symptoms. Doctors look at samples of blood and bone marrow to diagnose MDS. They also look for changes in the chromosomes of bone marrow cells (cytogenetics).

MDS can be hard to diagnose. Careful study of blood and marrow samples is needed to tell MDS apart from other diseases with similar signs and symptoms, such as aplastic anemia. Blood and marrow samples are often tested several times over two or more months to find out whether the disease is stable or getting worse.

MDS is a group of diseases that have many differences. It is important to diagnose the type of MDS to make the best treatment choices. With some types of MDS, a person may live with few symptoms for years, while other types can be life-threatening within months. In addition, some types of MDS are more likely than others to develop into acute myelogenous leukemia (AML). AML that develops from MDS can be hard to treat.